BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7035954)

  • 1. Health policy report. Funding the End-Stage Renal-Disease Program.
    Iglehart JK
    N Engl J Med; 1982 Feb; 306(8):492-6. PubMed ID: 7035954
    [No Abstract]   [Full Text] [Related]  

  • 2. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
    Maxwell JH; Sapolsky HM
    Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK
    N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of end-stage renal disease in Alabama.
    Melnick S
    Ala J Med Sci; 1983 Oct; 20(4):456-9. PubMed ID: 6359945
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare program; end-stage renal disease quality incentive program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Jan; 76(3):627-46. PubMed ID: 21261127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-care dialysis fits in with new economic challenges for providers.
    Usewicz MC
    Nephrol News Issues; 2011 Aug; 25(9):34-5. PubMed ID: 21905529
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare program; end-stage renal disease prospective payment system. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The government's kidney program.
    Kwitny MK
    Wall St J Midwest Ed; 1978 Feb; 58(94):18 concl. PubMed ID: 10306572
    [No Abstract]   [Full Text] [Related]  

  • 10. The politics of health cost containment: end-stage renal disease.
    Rettig RA
    Bull N Y Acad Med; 1980; 56(1):115-38. PubMed ID: 6986928
    [No Abstract]   [Full Text] [Related]  

  • 11. HCFA: failing to acknowledge the unique characteristics of the ESRD patient.
    Kanter A; Nidetz M
    Nephrol News Issues; 1990 Feb; 4(2):23-6, 31. PubMed ID: 2320135
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicare program; end-stage renal disease program; prospective reimbursement for dialysis services and approval of special purpose renal dialysis facilities--HCFA. Final rule.
    Fed Regist; 1983 May; 48(92):21254-91. PubMed ID: 10299129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feds finalizing payment cuts for dialysis.
    Med World News; 1983 Apr; 24(8):27. PubMed ID: 10259563
    [No Abstract]   [Full Text] [Related]  

  • 15. Home vs. in-center dialysis: reassessing the burdens.
    Schatell D
    Nephrol Nurs J; 2005; 32(3):347. PubMed ID: 16035476
    [No Abstract]   [Full Text] [Related]  

  • 16. Shifting sand: dialysis funding and modality distribution in Ontario.
    Mendelssohn DC; Blake PG
    Nephrol News Issues; 1999 Mar; 13(3):31-2, 37. PubMed ID: 10382486
    [No Abstract]   [Full Text] [Related]  

  • 17. The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace.
    Lowrie EG; Hampers CL
    N Engl J Med; 1981 Aug; 305(8):434-8. PubMed ID: 7019710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early history of dialysis for chronic renal failure in the United States: a view from Seattle.
    Blagg CR
    Am J Kidney Dis; 2007 Mar; 49(3):482-96. PubMed ID: 17336711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare program; end-stage renal disease (ESRD) payment exception requests and organ procurement costs--HCFA. Final rule.
    Fed Regist; 1997 Aug; 62(158):43657-74. PubMed ID: 10169837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.